维普期刊资源整合服务平台（V6.5）

58篇 您的检索式：作者名="Tanvetyanon"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Concurrent administration of interferon alfa-2b and beta-la显示文摘	Tanvetyanon T Stadtmauer EA Kerson LA	2003	Ann Pharmacother2003，37，1：	1
2	Neoadjuvant thera?py: an emerging concept in oncology显示文摘	Tanvetyanon T ClarkJI Campbell SC	2005	South MedJ2005，98，3：	1
3	Concurrent administration of interferon alfa-2b and beta-1a 显示文摘	Tanvetyanon T Stadtmauer EA Kerson LA	2003	Ann Pharmacother2003，37，1：	1
4	Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors显示文摘	Tanvetyanon T Hines E Jr	2004	Cancer2004，100，12：	1
5	Metastatectomy for extra-cranial extra-adrenal non small cell lung cancer solitary metastases: systematic review and analysis of reported cases显示文摘	SALAH S TANVETYANON T ABBASI S	2012	Lung Cancer2012，75，1：	1
6	Phase I / II study of the Src inhibitor dasatinib in combination with er- lotinib in advanced non-small-cell lung cancer 显示文摘	Haura EB Tanvetyanon T Chiappori A	2010	J Clin On- col2010，28，8：	1
7	Long - term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors 显示文摘	Tanvetyanon T Hines E Jr	2004	Cancer2004，100，12：	1
8	Severity,risk factors,and physician practices in the management of anemia during concurrent chemoradiation for head and neck carcinoma显示文摘	TANVETYANON T CHOUDHURY A M	2006	Cancer2006，106，7：	1
9	Phase Ⅰ / Ⅱ study of the Src inhibitor dasatinib in combination with erlotinib in ad- vanced non small-cell lung cancer显示文摘	Haura EB Tanvetyanon T Chiappori A	2010	J Clin Oncol2010，28，8：	1
10	Management of the adverse effects associated with intravenous bisphosphonates 显示文摘	Tanvetyanon T Stiff PJ	2006	Ann Oneol2006，17，6：	1
11	Phase Ⅱ efficacy and pharmacogenomic study of selumetinib (AZD6244;ARRY-142886) in 131Ⅰ refractory papillary thyroid carcinoma with or without follicular elements显示文摘	Hayes DN Lucas AS Tanvetyanon T		0，，：	1
12	Phase Ⅰ / Ⅱ study of the Src inhibitor dasatinib in combination with erlotinib in advanced nonl-small-cell lung cancer 显示文摘	HAURA EB TANVETYANON T CHIAPPORI A	2010	J Clin Onco12010，28，8：	1
13	Survival outcomes of squamous cell carcinoma arising from sinonasal inverted papilloma: report of 6 cases with systematic review and pooled analvsis显示文摘	Tanvetyanon T Qin D Padhya T	2009	Am J Otolarvngol2009，30，1：	1
14	Long-term efficacy and safety of zoledronie acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors 显示文摘	Tanvetyanon T Hines E Jr	2004	Cancer2004，100，12：	1
15	Metastatectomy for extra-cranial ex- tra-adrenal non-small cell lung cancer solitary metastases systematic review and analysis of reported cases 显示文摘	Salah S Tanvetyanon T Abbasi S	2012	Lung Cancer2012，75，1：	1
16	Outcomesofadrenalectomy- forisolated synchronous venus metachronous adrenal metastases in non-small-cell lung cancer: a systematic review and pooled analysis 显示文摘	Tanvetyanon T Robinson LA Schell MJ	2008	J Clin Oncol2008，26，7：	1
17	Outcomesof adrenalectomy for isolated synchronous versusmetachronous adrenal metastases in non-small*cel] lungcancer:a systematic review and pooled analysis 显示文摘	Tanvetyanon T Robinson LA Schell MJ	2008	J ClinOncol2008，26，7：	1
18	Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with non-small cell lung carcinoma and other solid tumors显示文摘	TANVETYANON T HINES E Jr	2005	Cancer2005，103，8：	1
19	Outcomes of adrena-lectomy for isolated synchronous versus metachronous adrenal metas-tases in non-small-cell lung cancer ? a systematic review and pooled a-nalysis显示文摘	Tanvetyanon T Robinson LA Schell MJ	2008	J Clin Oncol2008，26，7：	1
20	Mucopidermoid carcinoma of the lung presenting sa a cayitary lesion显示文摘	Tanvetyanon T Ratanatharathorn V Leopairat J	2004	J Med Assoc Thai2004，87，8：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示